Xuebijing Protects Against Septic Acute Liver Injury Based on Regulation of GSK-3β Pathway

• Main Authors: Liping Cao (Author), Zhenghong Li (Author), Yi Ren (Author), Mengmeng Wang (Author), Zhizhou Yang (Author), Wei Zhang (Author), Xiaoqin Han (Author), Mengya Yao (Author), Zhaorui Sun (Author), Shinan Nie (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Xuebijing (XBJ), the only drug approved for the sepsis and multiple organ dysfunction, and its protective effects against acute liver injury (ALI) and its mechanism. The aim of this study was to evaluate the protective effect of XBJ on cecal ligation and perforation (CLP)-induced mouse ALI model and...